EP Patent
EP0309477A1 — Ecteinascidins 729, 743, 745, 759a, 759b and 770.
Assigned to University of Illinois at Urbana Champaign · Expires 1989-04-05 · 37y expired
What this patent protects
New compounds are described, in particular ecteinascidins 729, 743, 745, 759A, 759B and 770 having antibacterial and antitumor properties.
USPTO Abstract
New compounds are described, in particular ecteinascidins 729, 743, 745, 759A, 759B and 770 having antibacterial and antitumor properties.
Drugs covered by this patent
- Zepzelca (LURBINECTEDIN) · Jazz Pharmaceuticals
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.